+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

EP PerMed Education Call

European Partnership for Personalised Medicine

The purpose of this call is to support the provision and development of educational content for healthcare professionals on the implementation of personalised medicine.

Submission

The objective of this Call is to provide subgrant funding to support the provision and development of educational content aimed at healthcare professionals (HCPs) in the implementation of personalised medicine (PM). The gaps in the PM knowledge and skills among HCPs have been identified as one key barrier to the implementation of PM. This initiative will enhance the capacity of HCPs to integrate PM into their daily practice, ensuring they are equipped with the necessary knowledge, skills, and competencies. The scope of this Call includes general and specialised education on PM and its implementation in clinical practice, interdisciplinary collaboration between HCPs, as well as effective communication of HCPs with patients. The courses will be designed and implemented collaboratively between selected consortia and EP PerMed.

The purpose of the Call is to fund high quality content that will feed into online modules/ courses, that will be collaboratively developed with the Digital Learning Team supporting EP PerMed. All modules/ courses will be hosted and disseminated through the EP PerMed website and the eLearning platform designated by EP PerMed.

Timeline

Date	Event
4 June 2025	Opening of the Call for Proposals submission
16 June 2025	Opening of application platform
18 June 2025 at 12:00 CEST	Call information webinar
16 June – 09 September 2025	Online matchmaking period
2 September 2025 at 12:00 CEST	Q&A online session
9 September 2025 at 16:00 CEST	Deadline for proposals submissions
10 – 16 September 2025	Eligibility check
17 September 2025	Notification of eligibility check outcome and invite to online pitches
6 – 10 October 2025	Online pitching sessions
29 October 2025	Final Results notification

AI Based Application Success Predictor

1. Transnational & Multi-Sector Consortium

Minimum 3 partners from 3 different EU/Associated countries, with no more than 2 partners per national funder.

Include academia, clinical/public health, and industry or non-profits to reflect the call's cross-sector ambition 

Optional: add patient/citizen organizations as extra partners .

2. Alignment with EP PerMed Strategic Agenda

All proposals must align with the Strategic Research & Innovation Agenda (SRIA) for personalised medicine, covering areas like patient stratification, omics, biomarkers, or PM implementation 

For JTC2025 ("PGxPM2025"), the focus is specifically on pharmacogenomics—from discovery to validation to dosage and response optimization using omics .

3. Innovation, Validation & Feasibility

Fast Track calls emphasize rigorous validation studies to bridge innovation-to-market gaps 

Venture Builder programs prioritize team composition (scientific, clinical, business), innovativeness, feasibility, sustainability, and patient impact

4. Clear & Realistic Project Design

Use 2-step submissions: ensure a competitive pre-proposal, then a strong full proposal (with rebuttal phase for JTC) 

Define measurable milestones, sustainable usage, and a clear path from discovery to implementation.

5. Sector Relevance & Stakeholder Inclusion

Include industry partners, regulators/HTA representatives, and patient/citizen organizations to support translational relevance 

Aim for interdisciplinary integration—mix biological/clinical and socio-economic or implementation sciences 

6. Full Compliance & Timing

Strictly follow application processes and use mandated templates, language, partner composition rules, and deadlines (common timeline: pre-proposal Feb 2025; full proposal Jun 2025) .

Dual submissions may be required (Call Secretariat and national funder portals, e.g., FWF) 

🔑 Summary Table

Predictor	Required Action
Transnational multi-sector consortium	3+ partners, academia/clinic/industry, patient orgs optional
Alignment with SRIA & topic standard	Address personalised medicine via biomarkers/omics or pharmacogenomics
Validation & feasibility focus	Define concrete milestones and real-world measures
Balanced team strength	Include scientific, clinical, business expertise
Stakeholder integration	Partner with regulators, HTA, patients
Compliance with structure & timeline	Pre-proposal > full proposal > rebuttal; use correct portals and templates

🛠 Pro Tips

Start your consortium early—meet geographic and sector requirements efficiently.

Map your aims to the SRIA, especially pharmacogenomics for JTC2025.

Highlight validation strategy: clear outcomes, data plans, proof-of-concept in real-world settings.

Draft a compelling team profile for Venture: describe founder skills, coachability, feasibility.

Include patient/HTA/regulator voices to strengthen translational readiness.

Use all guidance documents—call text, templates, national rules—during planning.

Specialties

General Medicine

Eligibility Requirements

For an application to proceed to evaluation, it must meet all the below eligibility criteria. Each application will be reviewed for this eligibility criteria by EP PerMed Partners.

Applicants must submit their proposal via the application platform before the deadline on 9 September 2025 at 16:00 CEST.
Applicants must use the templates provided in the application platform to submit their proposal.
Proposals may be submitted by organisations registered in an EU Member State or a Horizon Europe-associated country. The list of participating countries in Horizon Europe may be found here.
Partners/ Beneficiaries within the EP PerMed consortium and private persons are not eligible for this Call.
Applications must be written in English.
All modules must address a European audience.
Applications must request no more than 50,000 EUR (fifty thousand Euros) of funding including overheads.
Costs for a learning management system are not eligible for funding. This is provided by EP PerMed through EIT Health.
Costs for marketing and course promotion are not eligible for funding. This is provided by EP PerMed through its dissemination activities and the EP PerMed website.
Projects must last no longer than 12 months.

Consortium Composition eligibility

The consortium must include a minimum of two eligible organisations, independent of each other, each established in different European Member States or Associated Countries. Each of these consortium members must be eligible. All legal entities must be independent of each other.
Proposals may be submitted by applicants belonging to one of the following categories (eligibility of project partners may vary according to national/regional regulations):
- Academia: research teams working at universities, universities of applied sciences, other higher education institutions, research and knowledge dissemination organisations or research institutes;
- Clinical/public health sector: research teams working at hospitals, policlinics, medical practices, public health and/or other health care settings and health organisations;
- Companies: private companies of all sizes; CME/CPD companies/ agencies;
- Other stakeholders: e.g. citizen organisations, medical societies, local communities, local/national NGOs, consumer organisations. Other stakeholders should be in a position to provide useful knowledge and perspectives to the consortium.
At least one project consortium member must have validated experience in designing lifelong learning (adult learning) education activities, which is to be described in the application system.
At least one project consortium member must have validated experience in the implementation of personalised medicine which is to be described in the application system.
The maximum number of project consortium members in applying consortia is five.
At least one non-academic organisation.
The consortium must be complete at the time of submission.

Sponsor Details

Sponsor Institute/Organizations: European Partnership for Personalised Medicine

Sponsor Type: Corporate/Non-Profit

Address: Heinrich-Konen-Straße 5, 53227 Bonn, Germany

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity